Q2 2024 13F Holders as of 6/30/2024
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
106M
-
Number of holders
-
33
-
Total 13F shares, excl. options
-
4.06M
-
Shares change
-
-3.66M
-
Total reported value, excl. options
-
$4.83M
-
Value change
-
-$3.47M
-
Put/Call ratio
-
0.02
-
Number of buys
-
21
-
Number of sells
-
-10
-
Price
-
$1.19
Significant Holders of SELLAS Life Sciences Group, Inc. - Common Stock, par value $0.0001 per share (SLS) as of Q2 2024
44 filings reported holding SLS - SELLAS Life Sciences Group, Inc. - Common Stock, par value $0.0001 per share as of Q2 2024.
SELLAS Life Sciences Group, Inc. - Common Stock, par value $0.0001 per share (SLS) has 33 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 4.06M shares
of 106M outstanding shares and own 3.83% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (1.79M shares), GEODE CAPITAL MANAGEMENT, LLC (517K shares), BlackRock Inc. (430K shares), Opus Capital Group, LLC (221K shares), Equitable Holdings, Inc. (210K shares), Diametric Capital, LP (153K shares), MILLENNIUM MANAGEMENT LLC (150K shares), STATE STREET CORP (134K shares), NORTHERN TRUST CORP (101K shares), and Virtu Financial LLC (63.8K shares).
This table shows the top 33 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.